- Study type: Randomised Clinical Trial, Treatment
- Study type descriptors: Randomised controlled trial, Multicentre
- Objective: To evaluate the safety, tolerability and efficacy of two doses (dose A and dose B) of Standardized Conditioned Medium Obtained by Coculture of M2-macrophages and fat-derived Mesenchymal Stromal Cells (PRS CK STORM) in the modulation of the cytokine storm in participants with acute respiratory infection caused by SARS-Cov-2, influenza A, influenza B and respiratory syncytial virus (RSV) in need for oxygen therapy
- Number of participants enrolled: Enrollment ongoing
- Study enrolling from to
- Study includes follow-up for 1 year
Study Data
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Hospital
- Outpatient clinic
- SARS-CoV-2
- Respiratory syncytial virus
- Influenza virus
- Influenza A
- Influenza B
- Pharmacological intervention
- Immunomodulator
- PRS CK STORM
External Links
Other information
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to